<DOC>
	<DOCNO>NCT00702741</DOCNO>
	<brief_summary>The objective present study establish long-term safety intra-articular injection human mesenchymal stem cell ( hMSCs ) ( Chondrogen ) .</brief_summary>
	<brief_title>Follow-up Study ChondrogenÂ® Delivered Intra-Articular Injection Following Meniscectomy</brief_title>
	<detailed_description>The long-term safety human mesenchymal stem cell ( hMSCs ) ( Chondrogen ) yet establish . This 3-year follow-up study provide additional data gain understanding safety investigational agent . This study design determine safety single intra-articular injection 50 million donor-derived hMSCs 150 million donor-derived hMSCs suspension commercial sodium hyaluronan compare injection vehicle ( dilute hyaluronan ) alone . The injection perform initial study , Protocol No . 550 .</detailed_description>
	<criteria>Subject must receive injection Protocol No . 550 Subject must complete 6month final 2year visit Protocol No . 550 Subject must provide write informed consent entry extension study Subject must provide authorization use disclosure protect health information entry extension study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Knee</keyword>
	<keyword>Meniscus</keyword>
	<keyword>Meniscectomy</keyword>
	<keyword>Mesenchymal Stem Cells</keyword>
	<keyword>MSCs</keyword>
	<keyword>Adult Human Stem Cells</keyword>
	<keyword>Osiris</keyword>
	<keyword>Chondrogen</keyword>
</DOC>